Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Ugeskr Laeger ; 183(24)2021 06 14.
Article in Danish | MEDLINE | ID: mdl-34120687

ABSTRACT

Group B streptococcus (GBS) is a group of naturally occurring bacteria that colonises the anogenital region of every third pregnant woman. From the anogenital region they can colonise the urine and cause bacteriuria. It is well documented that treatment of GBS-bacteriuria with more than 104 colony forming units per millilitre (CFU/ml) reduces the risk of maternal and neonatal morbidity. There is, however, no clear evidence as summarised in this review that GBS-bacteriuria more than 104 CFU/ml increases the risk of maternal and neonatal morbidity which is why no treatment is warranted.


Subject(s)
Bacteriuria , Pregnancy Complications, Infectious , Streptococcal Infections , Bacteriuria/diagnosis , Bacteriuria/drug therapy , Female , Humans , Infant, Newborn , Pregnancy , Pregnancy Complications, Infectious/drug therapy , Pregnant Women , Streptococcal Infections/diagnosis , Streptococcal Infections/drug therapy , Streptococcus agalactiae
SELECTION OF CITATIONS
SEARCH DETAIL
...